Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by $25.8 million in TV ad spending, following a slip to sixth in January. Novo’s other GLP-1 giant, however, held steady ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback